Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability

References

• Ana R, Mendes M, Sousa J, et al. (2019). Rethinking carbamazepine oral delivery using polymer–lipid hybrid nanoparticles. Int J Pharm 554:352–65.
   PubMed Web of Science ®Google Scholar
• Bera K, Mazumder B, Khanam J. (2016). Study of the mucoadhesive potential of carbopol polymer in the preparation of microbeads containing the antidiabetic drug glipizide. AAPS PharmSciTech 17:743–56.
   PubMed Web of Science ®Google Scholar
• Burra M, Jukanti R, Janga KY, et al. (2013). Enhanced intestinal absorption and bioavailability of raloxifene hydrochloride via lyophilized solid lipid nanoparticles. Adv Powder Technol 24:393–402.
   Web of Science ®Google Scholar
• Chawla V, Saraf SA. (2012). Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac. Colloids Surf B Biointerfaces 92:293–8.
   PubMed Web of Science ®Google Scholar
• Dalmoro A, Bochicchio S, Nasibullin SF, et al. (2018). Polymer–lipid hybrid nanoparticles as enhanced indomethacin delivery systems. Eur J Pharm Sci 121:16–28.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan RB. (2012). Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139–51.
   PubMed Web of Science ®Google Scholar
• Deng W, Wang H, Wu B, Zhang X. (2019). Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect. Acta Pharm Sin B 9:74–86.
   PubMed Web of Science ®Google Scholar
• Du M, Ouyang Y, Meng F, et al. (2019). Polymer–lipid hybrid nanoparticles: a novel drug delivery system for enhancing the activity of Psoralen against breast cancer. Int J Pharm 561:274–82.
   PubMed Web of Science ®Google Scholar
• Elsheikh MA, Elnaggar YS, Gohar EY, Abdallah OY. (2012). Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomedicine 7:3787–802.
   PubMed Web of Science ®Google Scholar
• Fu Y, Kao WJ. (2010). Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 7:429–44.
   PubMed Web of Science ®Google Scholar
• Gou J, Liang Y, Miao L, et al. (2018). The promoting effect of enteric materials on the oral absorption of larotaxel-loaded polymer–lipid hybrid nanoparticles. Eur J Pharm Sci 124:288–94.
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, et al. (2013). The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci 49:175–86.
   PubMed Web of Science ®Google Scholar
• Hallan SS, Kaur V, Jain V, Mishra N. (2017). Development and characterization of polymer lipid hybrid nanoparticles for oral delivery of LMWH. Artif Cells Nanomed Biotechnol 45:1631–9.
   PubMed Web of Science ®Google Scholar
• Hochner-Celnikier D. (1999). Pharmacokinetics of raloxifene and its clinical application. Eur J Obstet Gynecol Reprod Biol 85:23–9.
   PubMed Web of Science ®Google Scholar
• Izgelov D, Cherniakov I, Aldouby Bier G, et al. (2018). The effect of piperine pro-nano lipospheres on direct intestinal phase II metabolism: the raloxifene paradigm of enhanced oral bioavailability. Mol Pharm 15:1548–55.
   PubMed Web of Science ®Google Scholar
• Jahangir MA, Khan R, Sarim Imam S. (2018). Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance. Artif Cells Nanomed Biotechnol 46:66–78.
   PubMed Web of Science ®Google Scholar
• Jain A, Kaur R, Beg S, et al. (2018). Novel cationic supersaturable nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes. Drug Deliv Transl Res 8:670–92.
   PubMed Web of Science ®Google Scholar
• Joyce P, Yasmin R, Bhatt A, et al. (2017). Comparison across three hybrid lipid-based drug delivery systems for improving the oral absorption of the poorly water-soluble weak base cinnarizine. Mol Pharm 14:4008–18.
   PubMed Web of Science ®Google Scholar
• Ko SS, Jordan VC. (2011). Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene. Expert Opin Pharmacother 12:657–74.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang B, Zhang X. (2019). Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption. Int J Pharm 568:118508.
   PubMed Web of Science ®Google Scholar
• Maghrebi S, Prestidge CA, Joyce P. (2019). An update on polymer–lipid hybrid systems for improving oral drug delivery. Expert Opin Drug Deliv 16:507–24.
   PubMed Web of Science ®Google Scholar
• Murugan K, Choonara YE, Kumar P, et al. (2015). Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine 10:2191–206.
   PubMed Web of Science ®Google Scholar
• Rao S, Prestidge CA. (2016). Polymer–lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery. Expert Opin Drug Deliv 13:691–707.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Aditya N, Kathuria H, et al. (2014). Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. Eur J Pharm Biopharm 87:114–24.
   PubMed Web of Science ®Google Scholar
• Reineke J, Cho DY, Dingle YL, et al. (2013). Can bioadhesive nanoparticles allow for more effective particle uptake from the small intestine? J Control Release 170:477–84.
   PubMed Web of Science ®Google Scholar
• Ren T, Wang Q, Xu Y, et al. (2018). Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer–lipid hybrid nanoparticles. J Control Release 269:423–38.
   PubMed Web of Science ®Google Scholar
• Salah S, Awad GEA, Makhlouf AIA. (2018). Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel: formulation development and in vivo therapeutic efficacy in rats. Eur J Pharm Sci 114:255–66.
   PubMed Web of Science ®Google Scholar
• Shah N, Seth A, Balaraman R, et al. (2018). Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study. Drug Dev Ind Pharm 44:687–96.
   PubMed Web of Science ®Google Scholar
• Shah NV, Seth AK, Balaraman R, et al. (2016). Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: design and in vivo study. J Adv Res 7:423–34.
   PubMed Web of Science ®Google Scholar
• Shah PV, Rajput SJ. (2018). Facile synthesis of chitosan capped mesoporous silica nanoparticles: a pH responsive smart delivery platform for raloxifene hydrochloride. AAPS PharmSciTech 19:1344–57.
   PubMed Web of Science ®Google Scholar
• Soni NK, Sonali LJ, Singh A, et al. (2020). Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment. Nanotechnology 31:475101.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Thongborisute J, Matsui Y, et al. (2005). Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev 57:1583–94.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Minaiyan M, Dayyani L. (2018). Poly(methyl vinyl ether-co-maleic acid) for enhancement of solubility, oral bioavailability and anti-osteoporotic effects of raloxifene hydrochloride. Eur J Pharm Sci 112:195–206.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Ziaei V, Minaiyan M, et al. (2019). Enhanced solubility, oral bioavailability and anti-osteoporotic effects of raloxifene HCl in ovariectomized rats by Igepal CO-890 nanomicelles. Pharm Dev Technol 24:133–44.
   PubMed Web of Science ®Google Scholar
• Varthya M, Pawar H, Singh C, et al. (2016). Development of novel polymer–lipid hybrid nanoparticles of tamoxifen: in vitro and in vivo evaluation. J Nanosci Nanotechnol 16:253–60.
   PubMed Web of Science ®Google Scholar
• Waheed A, Aqil M, Ahad A, et al. (2019). Improved bioavailability of raloxifene hydrochloride using limonene containing transdermal nano-sized vesicles. J Drug Deliv Sci Technol 52:468–76.
   Web of Science ®Google Scholar
• Wan F, Herzberg M, Huang Z, et al. (2020). A free-floating mucin layer to investigate the effect of the local microenvironment in lungs on mucin–nanoparticle interactions. Acta Biomater 104:115–23.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Y. (2018). Raloxifene/SBE-β-CD inclusion complexes formulated into nanoparticles with chitosan to overcome the absorption barrier for bioavailability enhancement. Pharmaceutics 10:76.
   PubMed Web of Science ®Google Scholar
• Xing H, Wang H, Wu B, Zhang X. (2018). Lipid nanoparticles for the delivery of active natural medicines. Curr Pharm Des 23:6705–13.
   Web of Science ®Google Scholar
• Yang C, Wu T, Qi Y, Zhang Z. (2018). Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics 8:464–85.
   PubMed Web of Science ®Google Scholar
• Ye Y, Zhang T, Li W, et al. (2016). Glucose-based mesoporous carbon nanospheres as functional carriers for oral delivery of amphiphobic raloxifene: insights into the bioavailability enhancement and lymphatic transport. Pharm Res 33:792–803.
   PubMed Web of Science ®Google Scholar
• Yin J, Hou Y, Song X, et al. (2019). Cholate-modified polymer–lipid hybrid nanoparticles for oral delivery of quercetin to potentiate the antileukemic effect. Int J Nanomedicine 14:4045–57.
   PubMed Web of Science ®Google Scholar
• Yin J, Hou Y, Yin Y, Song X. (2017a). Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect. Int J Nanomedicine 12:8671–80.
   PubMed Web of Science ®Google Scholar
• Yin J, Wang P, Yin Y, et al. (2017b). Optimization on biodistribution and antitumor activity of tripterine using polymeric nanoparticles through RES saturation. Drug Deliv 24:1891–7.
   PubMed Web of Science ®Google Scholar
• Yin J, Xiang C, Song X. (2016). Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability. Int J Pharm 510:203–9.
   PubMed Web of Science ®Google Scholar
• Yin J, Xiang C, Wang P, et al. (2017c). Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability. Int J Nanomedicine 12:2923–31.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang T, Ye Y, et al. (2015). Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect. Eur J Pharm Biopharm 94:30–41.
   PubMed Web of Science ®Google Scholar